Statins and prevention of stent-related late adverse events

Coron Artery Dis. 2014 Jun;25(4):277-8. doi: 10.1097/MCA.0000000000000116.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Coronary Artery Disease / therapy*
  • Coronary Vessels / drug effects*
  • Drug-Eluting Stents*
  • Female
  • Fluorobenzenes / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Neointima*
  • Percutaneous Coronary Intervention / instrumentation*
  • Pravastatin / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Rosuvastatin Calcium
  • Sulfonamides / therapeutic use*

Substances

  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium
  • Pravastatin